This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by David, S. Articles by Zaks, J. M. Search for Related Content PubMed PubMed Citation Articles by David, S. Articles by Zaks, J. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Arrhythmia Social Bookmarking                         What's this?

Arrhythmias Associated with Intermittent Outpatient Dobutamine Infusion

Providence Hospital, Southfield, Michigan

Jeffrey M. Zaks

Providence Hospital, Southfield, Michigan

The use of intermittent outpatient dobutamine infusion has recently been studied as an alternative therapy modality for patients with refractory conges tive heart failure. We studied the arrhythmogenic effects of intermittent outpa tient dobutamine infusion in two patients with NYHA class IV heart failure. The patients received dobutamine at 5mcg./kg./min. for four hours per day for an eight week period. Ambulatory Holter monitoring was obtained during the infusion periods and compared to infusion-free periods. A significant increase of complex ventricular- arrhythmias, including multifocal PVC's and ventricu lar tachycardias, was observed during the infusion period. The incidence of complex ventricular ectopy was dose related and could be suppressed to baseline levels with appropriate antiarrhythmic therapy. We concluded that dobutamine is extremely arrhythmogenic when used in patients with heart failure and that this effect was controllable with antiarrhythmics. Extreme caution and careful monitoring is required for this new therapeutic modality in the treatment of refractory heart failure.

Angiology, Vol. 37, No. 2, 86-91 (1986)
DOI: 10.1177/000331978603700203


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. W. Stevenson Clinical Use of Inotropic Therapy for Heart Failure: Looking Backward or Forward?: Part II: Chronic Inotropic Therapy Circulation, July 29, 2003; 108(4): 492 - 497. [Full Text] [PDF]

				B. Puram, J. Margolis, and V. Puram Prolonged Beneficial Effects of Dobutamine in Refractory Heart Failure Case Histories Angiology, August 1, 1987; 38(8): 631 - 634. [Abstract] [PDF]